Pravin Vishnu Badadhe
Research Subjects
Pravin Vishnu Badadhe has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Asha V. Chate
Dr. Babasaheb Ambedkar Marathwada University
3 shared publicationsCharansingh H. Gill
3 shared publications- Aruna S. Shinde
P. G. Department of Chemistry and Research Centre, R. B. Narayanrao Borawake College, Shrirampur, M.S., India 413709
2 shared publications Ashis Nandy
Aragen Life Sciences Ltd, Survey No. 125 and 126, IDA, Mallapur, Hyderabad, Telangana, 500 076, India
2 shared publicationsC. H. Gill
Dep. Chem., Marathwada Univ., Aurangabad 431 004, India
2 shared publications- Charansingh. H. Gill
Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (46) , 60671-60680
Synthesis and evaluation of the antimicrobial activity of novel esters, β-diketones, chromones and pyrazoles
A new series of 2-acetylphenyl 6-chloropyridine-2-carboxylates was synthesized and converted into 1,3-diketones via the Baker–Venkataraman rearrangement for constructing chromone and pyrazole frameworks.
- 21 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (46) , 60671-60680
Open AccessSynthesis and evaluation of the antimicrobial activity of novel esters, β-diketones, chromones and pyrazoles
A new series of 2-acetylphenyl 6-chloropyridine-2-carboxylates was synthesized and converted into 1,3-diketones via the Baker–Venkataraman rearrangement for constructing chromone and pyrazole frameworks.
- 8 October 2026
- Published by Wiley in Journal of Peptide Science
- Vol. 32 (11)
Greener Liquid‐Phase Synthesis of Pseudoproline Dipeptide Building Blocks in Ethanol and Water
A sustainable synthetic strategy for Fmoc‐protected pseudoproline dipeptides was developed to address the environmental and operational limitations of traditional solvent‐intensive methods. By utilizing ethanol as solvent during cyclisation, activated ester formation, and coupling steps, this approach eliminates the need for hazardous conventional solvents while simplifying the overall process. The protocol consistently delivers pseudoproline dipeptides in high yields and with excellent purity, demonstrating that environmentally friendly modifications can maintain strong synthetic performance. In addition to its operational simplicity and scalability, the method significantly reduces solvent‐related hazards, minimizes waste generation, and improves key green chemistry. This practical and versatile methodology provides a cleaner, more sustainable platform for the synthesis of pseudoproline‐containing intermediates relevant to peptide and pharmaceutical manufacturing.
- 8 October 2026
- Published by Wiley in Journal of Peptide Science
- Vol. 32 (11)
Greener Liquid‐Phase Synthesis of Pseudoproline Dipeptide Building Blocks in Ethanol and Water
A sustainable synthetic strategy for Fmoc‐protected pseudoproline dipeptides was developed to address the environmental and operational limitations of traditional solvent‐intensive methods. By utilizing ethanol as solvent during cyclisation, activated ester formation, and coupling steps, this approach eliminates the need for hazardous conventional solvents while simplifying the overall process. The protocol consistently delivers pseudoproline dipeptides in high yields and with excellent purity, demonstrating that environmentally friendly modifications can maintain strong synthetic performance. In addition to its operational simplicity and scalability, the method significantly reduces solvent‐related hazards, minimizes waste generation, and improves key green chemistry. This practical and versatile methodology provides a cleaner, more sustainable platform for the synthesis of pseudoproline‐containing intermediates relevant to peptide and pharmaceutical manufacturing.
- Open Access
- 7 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (44) , 54674-54690
Design, synthesis, molecular docking and anticancer activity of novel N -(4-(chlorodifluoromethoxy)phenyl)-1 H -pyrrolo[2,3- b ]pyridine-5-carboxamide derivatives
New N -(4-(chlorodifluoromethoxy)phenyl)-1 H -pyrrolo[2,3- b ]pyridine-5-carboxamide derivatives were designed, synthesised, and evaluated as potential anticancer agents.
- 7 October 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (44) , 54674-54690
Open AccessDesign, synthesis, molecular docking and anticancer activity of novel N -(4-(chlorodifluoromethoxy)phenyl)-1 H -pyrrolo[2,3- b ]pyridine-5-carboxamide derivatives
New N -(4-(chlorodifluoromethoxy)phenyl)-1 H -pyrrolo[2,3- b ]pyridine-5-carboxamide derivatives were designed, synthesised, and evaluated as potential anticancer agents.
- Open Access
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
Novel N-(4-(Chlorodifluoromethoxy)phenyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives: Design, Synthesis, Molecular Modeling Investigation and Anticancer Activity in various cell lines
A novel series of N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives (9a–9p) were synthesized and tested for anticancer activity against multiple human cancer cell lines including K562, A549, CCRF-CEM, HCT116, HCT116 p53−/−, U2OS along with normal human fibroblast cell lines BJ and MRC-5. Significant emphasis was placed on the K562 cell line, an established model for BCR-ABL1-positive Chronic Myeloid Leukemia. Compound 9c has good potency with an IC₅₀ value of 0.22 ± 0.034 µM and selectivity (SI >100) against normal fibroblast cells such as BJ and MRC-5 cell lines. Compounds 9a (IC₅₀ = 0.82 ± 0.091 µM), followed by 9k (0.53 ± 0.04 µM), 9l (0.91 ± 0.092 µM) and 9b (0.98 ± 0.18 µM) showed good activity with favourable selectivity index (>30), however the reference drug Asciminib has remained superior with an IC50 value of 0.005 ± 0.001 µM and selectivity index value of >10000. Overall, the good activity of these compounds against K562 cells suggests a possible BCR-ABL1-related mechanism. Molecular docking studies revealed good binding affinities, with compound 9b showing the good Glide score (−8.11 kcal/mol). Although enzyme inhibition assays were not conducted but the observed selective cytotoxicity in K562 cells indicates potential modulation of BCR-ABL1 mediated signalling pathways.
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNovel N-(4-(Chlorodifluoromethoxy)phenyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives: Design, Synthesis, Molecular Modeling Investigation and Anticancer Activity in various cell lines
A novel series of N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide derivatives (9a–9p) were synthesized and tested for anticancer activity against multiple human cancer cell lines including K562, A549, CCRF-CEM, HCT116, HCT116 p53−/−, U2OS along with normal human fibroblast cell lines BJ and MRC-5. Significant emphasis was placed on the K562 cell line, an established model for BCR-ABL1-positive Chronic Myeloid Leukemia. Compound 9c has good potency with an IC₅₀ value of 0.22 ± 0.034 µM and selectivity (SI >100) against normal fibroblast cells such as BJ and MRC-5 cell lines. Compounds 9a (IC₅₀ = 0.82 ± 0.091 µM), followed by 9k (0.53 ± 0.04 µM), 9l (0.91 ± 0.092 µM) and 9b (0.98 ± 0.18 µM) showed good activity with favourable selectivity index (>30), however the reference drug Asciminib has remained superior with an IC50 value of 0.005 ± 0.001 µM and selectivity index value of >10000. Overall, the good activity of these compounds against K562 cells suggests a possible BCR-ABL1-related mechanism. Molecular docking studies revealed good binding affinities, with compound 9b showing the good Glide score (−8.11 kcal/mol). Although enzyme inhibition assays were not conducted but the observed selective cytotoxicity in K562 cells indicates potential modulation of BCR-ABL1 mediated signalling pathways.
- 26 November 2025
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 201 (3) , 272-277
Synthesis of thiazolidin-4-one derivatives via green imine intermediates catalyzed by Caralluma fimbriata
- 26 November 2025
- Published by Taylor & Francis in Phosphorus, Sulfur, and Silicon and the Related Elements
- Vol. 201 (3) , 272-277
Synthesis of thiazolidin-4-one derivatives via green imine intermediates catalyzed by Caralluma fimbriata
- 31 May 2016
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 54 (2) , 1109-1120
An Organocatalyzed Efficient One‐pot Synthesis, Biological Evaluation, and Molecular Docking Studies of 4,4′‐(Arylmethylene)bis‐(3‐methyl‐1‐phenyl‐1H‐pyrazol‐5‐ols)
The synthesis of 4,4′‐(arylmethylene)bis‐(3‐methyl‐1‐phenyl‐1H‐pyrazol‐5‐ol) derivatives catalyzed by ʟ‐proline is a simple, versatile, and efficient method. In vitro antioxidant, anti‐inflammatory, and antimicrobial activities of compounds 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h, 4i, 4j were studied. Furthermore, to rationalize the observed anti‐inflammatory activity data, molecular docking study has been performed against COX‐2 enzyme which revealed a good binding affinity for these molecules and could provide an insight into the various bonded and non‐bonded interactions guiding their binding affinity.
- 31 May 2016
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 54 (2) , 1109-1120
An Organocatalyzed Efficient One‐pot Synthesis, Biological Evaluation, and Molecular Docking Studies of 4,4′‐(Arylmethylene)bis‐(3‐methyl‐1‐phenyl‐1H‐pyrazol‐5‐ols)
The synthesis of 4,4′‐(arylmethylene)bis‐(3‐methyl‐1‐phenyl‐1H‐pyrazol‐5‐ol) derivatives catalyzed by ʟ‐proline is a simple, versatile, and efficient method. In vitro antioxidant, anti‐inflammatory, and antimicrobial activities of compounds 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h, 4i, 4j were studied. Furthermore, to rationalize the observed anti‐inflammatory activity data, molecular docking study has been performed against COX‐2 enzyme which revealed a good binding affinity for these molecules and could provide an insight into the various bonded and non‐bonded interactions guiding their binding affinity.
- 10 October 2014
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 41 (10) , 7509-7516
Lithium bromide catalyzed efficient and convenient synthesis of 2-arylbenzothiazole derivatives
- 10 October 2014
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 41 (10) , 7509-7516
Lithium bromide catalyzed efficient and convenient synthesis of 2-arylbenzothiazole derivatives
- 16 July 2013
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 50 (5) , 999-1004
Synthesis and Antimicrobial Screening of Some Novel Chromones and Pyrazoles with Incorporated Isoxazole Moieties
The title compounds 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h and 6a, 6b, 6c, 6d, 6e, 6f, 6g, 6h have been synthesized from β‐diketones and chromones, respectively, having 5‐methyl‐3‐phenylisoxazole moiety. Substituted 2‐acetylphenyl 5‐methyl‐3‐phenylisoxazole‐4‐carboxylate 3a, 3b, 3c, 3d, 3e, 3f, 3g, 3h were converted into 1‐(2‐hydroxyphenyl)‐3‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)propane‐1,3‐dione 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h by Baker–Venketaraman transformation. Further, the cyclodehydration of diketone 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h with glacial acetic acid in conc. HCl at reflux gave corresponding substituted 2‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐4H‐chromen‐4‐one 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h. The corresponding 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h react with hydrazine hydrate in presence of glacial acetic acid in ethanol at reflux to furnish 2‐(5‐5(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐1H‐pyrazole‐3‐yl)phenol 6a, 6b, 6c, 6d, 6e, 6f, 6g, 6h. The structures of all newly synthesized compounds have been confirmed by IR, 1H NMR, mass spectral data, as well as elemental analysis. The synthesized compounds have been screened for their antimicrobial activity. Some of the compounds show better antimicrobial activity as compared with the reference drugs Streptomycin, Ampicillin, Gentamycin, Cefixime, and Ketoconazole.
- 16 July 2013
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 50 (5) , 999-1004
Synthesis and Antimicrobial Screening of Some Novel Chromones and Pyrazoles with Incorporated Isoxazole Moieties
The title compounds 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h and 6a, 6b, 6c, 6d, 6e, 6f, 6g, 6h have been synthesized from β‐diketones and chromones, respectively, having 5‐methyl‐3‐phenylisoxazole moiety. Substituted 2‐acetylphenyl 5‐methyl‐3‐phenylisoxazole‐4‐carboxylate 3a, 3b, 3c, 3d, 3e, 3f, 3g, 3h were converted into 1‐(2‐hydroxyphenyl)‐3‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)propane‐1,3‐dione 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h by Baker–Venketaraman transformation. Further, the cyclodehydration of diketone 4a, 4b, 4c, 4d, 4e, 4f, 4g, 4h with glacial acetic acid in conc. HCl at reflux gave corresponding substituted 2‐(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐4H‐chromen‐4‐one 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h. The corresponding 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h react with hydrazine hydrate in presence of glacial acetic acid in ethanol at reflux to furnish 2‐(5‐5(5‐methyl‐3‐phenylisoxazole‐4‐yl)‐1H‐pyrazole‐3‐yl)phenol 6a, 6b, 6c, 6d, 6e, 6f, 6g, 6h. The structures of all newly synthesized compounds have been confirmed by IR, 1H NMR, mass spectral data, as well as elemental analysis. The synthesized compounds have been screened for their antimicrobial activity. Some of the compounds show better antimicrobial activity as compared with the reference drugs Streptomycin, Ampicillin, Gentamycin, Cefixime, and Ketoconazole.
- Open Access
- 1 January 2012
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 19 (1) , 94-96
Ultrasound assisted one pot synthesis of imidazole derivatives using diethyl bromophosphate as an oxidant
- 1 January 2012
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 19 (1) , 94-96
Open AccessUltrasound assisted one pot synthesis of imidazole derivatives using diethyl bromophosphate as an oxidant
- 22 December 2011
- Published by Wiley in ChemInform
- Vol. 43 (3)
ChemInform Abstract: Synthesis of Some Biologically Important Pyrazoles and Pyrazoline Derivatives
Starting from chalcone derivatives (III)
- 22 December 2011
- Published by Wiley in ChemInform
- Vol. 43 (3)
ChemInform Abstract: Synthesis of Some Biologically Important Pyrazoles and Pyrazoline Derivatives
Starting from chalcone derivatives (III)